HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
10 sources retrieved Β· Most recent: April 2026 Β· Index updated 15 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
BSCL2
BSCL2 lipid droplet biogenesis associated, seipin
Chromosome 11 Β· 11q12.3
NCBI Gene: 26580Ensembl: ENSG00000168000.16HGNC: HGNC:15832UniProt: A0A024R549
135PubMed Papers
24Diseases
0Drugs
56Pathogenic Variants
RESEARCH IMPACT
Variant-Rich
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
lipid droplet formationendoplasmic reticulum membranelipid dropletlipid droplet organizationcongenital generalized lipodystrophy type 2Autosomal dominant spastic paraplegia type 17neuronopathy, distal hereditary motor, type 5Chereditary spastic paraplegia 17
✦AI Summary

BSCL2 encodes seipin, a protein essential for lipid droplet biogenesis and cellular energy metabolism. Seipin plays a crucial role in the formation and maturation of lipid droplets, which serve as storage organelles central to lipid and energy homeostasis 1. The protein localizes to endoplasmic reticulum-mitochondria contact sites (MAMs) where it regulates mitochondrial calcium import and metabolism 2. Seipin associates with calcium regulators including SERCA2, IP3R, and VDAC, and its removal leads to defective mitochondrial calcium influx, reduced Krebs cycle metabolites, and decreased ATP levels 2. Mutations in BSCL2 cause multiple distinct clinical phenotypes depending on the specific variant. Loss-of-function mutations typically result in congenital generalized lipodystrophy type 2 (Berardinelli-Seip syndrome), characterized by lipoatrophy, metabolic complications, and insulin resistance 3. Specific variants like c.985C>T cause Celia's encephalopathy, a progressive neurological disorder with poor prognosis due to aberrant seipin accumulation in neurons 4. Additional BSCL2 mutations are associated with hereditary spastic paraplegia type 17 and distal hereditary motor neuropathy, highlighting the protein's importance in neuronal function 56. The diverse clinical manifestations underscore seipin's critical roles in both metabolic and neurological systems.

Sources cited
1
Seipin plays a crucial role in lipid droplet formation and energy homeostasis
PMID: 33794741
2
Seipin localizes to ER-mitochondria contact sites and regulates mitochondrial calcium import and metabolism
PMID: 35021082
3
BSCL2 mutations cause congenital generalized lipodystrophy with metabolic complications
PMID: 41841805
4
Specific BSCL2 variant c.985C>T causes Celia's encephalopathy through aberrant protein accumulation
PMID: 33916074
5
BSCL2 mutations are associated with distal hereditary motor neuropathy
PMID: 38702287
6
BSCL2 mutations cause hereditary spastic paraplegia type 17
PMID: 23897027
Disease Associationsβ“˜24
congenital generalized lipodystrophy type 2Open Targets
0.80Strong
Autosomal dominant spastic paraplegia type 17Open Targets
0.77Strong
neuronopathy, distal hereditary motor, type 5COpen Targets
0.76Strong
hereditary spastic paraplegia 17Open Targets
0.76Strong
severe neurodegenerative syndrome with lipodystrophyOpen Targets
0.75Strong
neuronopathy, distal hereditary motor, type 5AOpen Targets
0.56Moderate
Charcot-Marie-Tooth disease type 2Open Targets
0.55Moderate
genetic disorderOpen Targets
0.49Moderate
Distal hereditary motor neuropathy type 5Open Targets
0.46Moderate
lipodystrophyOpen Targets
0.46Moderate
Berardinelli-Seip congenital lipodystrophyOpen Targets
0.42Moderate
hereditary spastic paraplegiaOpen Targets
0.42Moderate
monogenic diabetesOpen Targets
0.40Moderate
congenital generalized lipodystrophyOpen Targets
0.39Weak
distal hereditary motor neuropathyOpen Targets
0.37Weak
peripheral neuropathyOpen Targets
0.34Weak
breast carcinomaOpen Targets
0.33Weak
Neutrophilia in presence of infectionOpen Targets
0.33Weak
Reduced delayed hypersensitivityOpen Targets
0.33Weak
Triangular shaped proximal phalanx of the thumbOpen Targets
0.33Weak
Encephalopathy, progressive, with or without lipodystrophyUniProt
Lipodystrophy, congenital generalized, 2UniProt
Neuronopathy, distal hereditary motor, autosomal dominant 13UniProt
Spastic paraplegia 17, autosomal dominantUniProt
Pathogenic Variants56
NM_001122955.4(BSCL2):c.461C>T (p.Ser154Leu)Pathogenic
Hereditary spastic paraplegia 17|not provided|Neuronopathy, distal hereditary motor, type 5A;Hereditary spastic paraplegia 17|Charcot-Marie-Tooth disease type 2|Neuronopathy, distal hereditary motor, type 5C|Abnormal central motor function|Berardinelli-Seip congenital lipodystrophy|BSCL2-related disorder
β˜…β˜…β˜†β˜†2025β†’ Residue 154
NM_001122955.4(BSCL2):c.828del (p.Tyr277fs)Pathogenic
Congenital generalized lipodystrophy type 2|Charcot-Marie-Tooth disease type 2|Berardinelli-Seip congenital lipodystrophy|Severe neurodegenerative syndrome with lipodystrophy;Congenital generalized lipodystrophy type 2
β˜…β˜…β˜†β˜†2025β†’ Residue 277
NM_001122955.4(BSCL2):c.509_513del (p.Tyr170fs)Pathogenic
Congenital generalized lipodystrophy type 2|Severe neurodegenerative syndrome with lipodystrophy|not provided|Charcot-Marie-Tooth disease type 2|Berardinelli-Seip congenital lipodystrophy
β˜…β˜…β˜†β˜†2024β†’ Residue 170
NM_001122955.4(BSCL2):c.825dup (p.Ala276fs)Likely pathogenic
Lipodystrophy|Congenital generalized lipodystrophy type 2;Neuronopathy, distal hereditary motor, type 5C;Hereditary spastic paraplegia 17;Severe neurodegenerative syndrome with lipodystrophy
β˜…β˜…β˜†β˜†2024β†’ Residue 276
NM_001122955.4(BSCL2):c.985C>T (p.Arg329Ter)Pathogenic
Severe neurodegenerative syndrome with lipodystrophy|Congenital generalized lipodystrophy type 2|Charcot-Marie-Tooth disease type 2|Berardinelli-Seip congenital lipodystrophy
β˜…β˜…β˜†β˜†2024β†’ Residue 329
NM_001122955.4(BSCL2):c.974dup (p.Ile326fs)Pathogenic
Congenital generalized lipodystrophy type 2|Charcot-Marie-Tooth disease type 2|not provided|Severe neurodegenerative syndrome with lipodystrophy;Neuronopathy, distal hereditary motor, type 5C;Congenital generalized lipodystrophy type 2;Hereditary spastic paraplegia 17|Berardinelli-Seip congenital lipodystrophy|BSCL2-related disorder|Severe neurodegenerative syndrome with lipodystrophy|Severe neurodegenerative syndrome with lipodystrophy;Congenital generalized lipodystrophy type 2
β˜…β˜…β˜†β˜†2024β†’ Residue 326
NM_001122955.4(BSCL2):c.1361_1386del (p.Arg454fs)Pathogenic
Charcot-Marie-Tooth disease type 2|Severe neurodegenerative syndrome with lipodystrophy;Congenital generalized lipodystrophy type 2;Hereditary spastic paraplegia 17;Neuronopathy, distal hereditary motor, type 5C
β˜…β˜…β˜†β˜†2024β†’ Residue 454
NM_001122955.4(BSCL2):c.486+1G>APathogenic
Charcot-Marie-Tooth disease type 2|not provided|Hereditary spastic paraplegia 17;Severe neurodegenerative syndrome with lipodystrophy;Neuronopathy, distal hereditary motor, type 5C;Congenital generalized lipodystrophy type 2
β˜…β˜…β˜†β˜†2024
NM_001122955.4(BSCL2):c.942dup (p.Leu315fs)Pathogenic
Congenital generalized lipodystrophy type 2
β˜…β˜…β˜†β˜†2024β†’ Residue 315
NM_001122955.4(BSCL2):c.826G>C (p.Ala276Pro)Pathogenic
Congenital generalized lipodystrophy type 2|Berardinelli-Seip congenital lipodystrophy|Severe neurodegenerative syndrome with lipodystrophy;Congenital generalized lipodystrophy type 2;Neuronopathy, distal hereditary motor, type 5C;Hereditary spastic paraplegia 17|Charcot-Marie-Tooth disease type 2
β˜…β˜…β˜†β˜†2024β†’ Residue 276
NM_001122955.4(BSCL2):c.757G>T (p.Glu253Ter)Pathogenic
Congenital generalized lipodystrophy type 2|Charcot-Marie-Tooth disease type 2|Berardinelli-Seip congenital lipodystrophy
β˜…β˜…β˜†β˜†2023β†’ Residue 253
NM_001122955.4(BSCL2):c.461C>G (p.Ser154Trp)Pathogenic
Charcot-Marie-Tooth disease type 2|Charcot-Marie-Tooth disease|Neuronopathy, distal hereditary motor, type 5C|Hereditary spastic paraplegia 17|Berardinelli-Seip congenital lipodystrophy
β˜…β˜…β˜†β˜†2023β†’ Residue 154
NM_001122955.4(BSCL2):c.517dup (p.Thr173fs)Pathogenic
Congenital generalized lipodystrophy type 2|Severe neurodegenerative syndrome with lipodystrophy;Congenital generalized lipodystrophy type 2;Neuronopathy, distal hereditary motor, type 5C;Hereditary spastic paraplegia 17|Berardinelli-Seip congenital lipodystrophy|Charcot-Marie-Tooth disease type 2
β˜…β˜…β˜†β˜†2023β†’ Residue 173
NM_001122955.4(BSCL2):c.604C>T (p.Arg202Ter)Pathogenic
Congenital generalized lipodystrophy type 2|Inborn genetic diseases|Neuronopathy, distal hereditary motor, type 5C|Berardinelli-Seip congenital lipodystrophy
β˜…β˜…β˜†β˜†2022β†’ Residue 202
NM_001122955.4(BSCL2):c.1006-2A>GPathogenic
not provided|Congenital generalized lipodystrophy type 2
β˜…β˜…β˜†β˜†2017
NM_001122955.4(BSCL2):c.844_854del (p.Ala282fs)Pathogenic
Congenital generalized lipodystrophy type 2|Lipodystrophy|Berardinelli-Seip congenital lipodystrophy
β˜…β˜…β˜†β˜†2016β†’ Residue 282
NM_001122955.4(BSCL2):c.631-1G>CPathogenic
Monogenic diabetes|Severe neurodegenerative syndrome with lipodystrophy;Congenital generalized lipodystrophy type 2
β˜…β˜…β˜†β˜†2015
NM_001122955.4(BSCL2):c.1006-2A>TLikely pathogenic
Charcot-Marie-Tooth disease type 2
β˜…β˜†β˜†β˜†2025
NM_001122955.4(BSCL2):c.630+1G>TPathogenic
Congenital generalized lipodystrophy type 2
β˜…β˜†β˜†β˜†2025
NM_001122955.4(BSCL2):c.1006-2A>CLikely pathogenic
Charcot-Marie-Tooth disease type 2
β˜…β˜†β˜†β˜†2025
View on ClinVar β†—
Related Genes
CAV1Protein interaction92%TMEM19Protein interaction81%LMNAProtein interaction81%ZMPSTE24Protein interaction80%REEP1Protein interaction78%CA10Protein interaction77%
Tissue Expression6 tissues
Brain
100%
Ovary
27%
Liver
22%
Bone Marrow
18%
Lung
18%
Heart
10%
Gene Interaction Network
Click a node to explore
BSCL2CAV1TMEM19LMNAZMPSTE24REEP1CA10
PROTEIN STRUCTURE
Preparing viewer…
PDB6DS5 Β· 3.80 Γ… Β· EM
View on RCSB β†—
Constraintβ“˜
LOEUFβ“˜
0.87LoF Tolerant
pLIβ“˜
0.00Tolerant
Observed/Expected LoF0.67 [0.52–0.87]
RankingsWhere BSCL2 stands among ~20K protein-coding genes
  • #3,423of 20,598
    Most Researched135 Β· top quartile
  • #1,226of 5,498
    Most Pathogenic Variants56 Β· top quartile
  • #7,650of 17,882
    Most Constrained (LOEUF)0.87
Genes detectedBSCL2
Sources retrieved10 papers
Response timeβ€”
πŸ“„ Sources
10β–Ό
1
Distal hereditary motor neuropathies.
PMID: 38702287
Rev Neurol (Paris) Β· 2024
1.00
2
The mΓ©nage Γ  trois of autophagy, lipid droplets and liver disease.
PMID: 33794741
Autophagy Β· 2022
0.90
3
A 20-year Clinical and Genetic Neuromuscular Cohort Analysis in Lebanon: An International Effort.
PMID: 34602496
J Neuromuscul Dis Β· 2022
0.80
4
Neonatal diabetes mellitus around the world: Update 2024.
PMID: 39344692
J Diabetes Investig Β· 2024
0.70
5
Hereditary spastic paraplegia: clinico-pathologic features and emerging molecular mechanisms.
PMID: 23897027
Acta Neuropathol Β· 2013
0.60